CERTIFICATE
OF OWNERSHIP
MERGING
Sensivida
Medical Systems, Inc.
(a
Delaware corporation)
(the
“Subsidiary Corporation”)
Into
BioScopix,
Inc.
(a
New Jersey corporation)
____________________________________
Pursuant
to Section 253 of the Delaware General Corporation Law and
Section
14A:10-7 of the New Jersey Business Corporation Act
____________________________________
It is
hereby certified that:
1. BioScopix,
Inc. (the “Corporation” or sometimes the “Surviving Corporation”) is a business
corporation of the State of New Jersey. The Restated Certificate of
Incorporation of the Corporation was filed with the State of New Jersey on
December 10, 2004.
2. Sensivida
Medical Systems, Inc. (the “Subsidiary Corporation”) is a business corporation
of the State of Delaware. The Certificate of Incorporation of the
Subsidiary Corporation was filed with the Secretary of State of the State of
Delaware on October 26, 2005.
3. The
Corporation is the owner of all 88,000 issued and outstanding shares of common
stock, par value $0.001 per share, of the Subsidiary Corporation, which common
stock constitutes all of the issued and outstanding capital stock of the
Subsidiary Corporation.
4. The
New Jersey Business Corporation Act and the Delaware General Corporation Law
each permits the merger of a business corporation of that jurisdiction with a
business corporation of a foreign jurisdiction.
5. The
Corporation hereby merges the Subsidiary Corporation into the
Corporation.
6. At
the Effective Time of the Merger, the name of the Surviving Corporation shall be
changed to “SensiVida Medical Technologies, Inc.”
7. At
the Effective Time of the Merger, the Restated Certificate of Incorporation of
the Corporation shall be the Certificate of Incorporation of the Surviving
Corporation and the Bylaws of the Corporation shall be the Bylaws of the
Surviving Corporation.
8. The
following is a copy of the resolutions adopted on February 10, 2009 by the Board
of Directors of the Corporation to merge the Subsidiary Corporation into the
Corporation:
NOW,
THEREFORE, BE IT RESOLVED, that the Corporation is hereby authorized and
empowered to enter into, execute, deliver and perform its obligations under the
Merger Agreement, pursuant to which the Subsidiary Corporation will be merged
into the Corporation and the Corporation will survive the merger as the
Surviving Corporation; said Merger Agreement to be in substantially the form
attached hereto as Exhibit A, with such changes, modifications or amendments
thereto as the officers, or any one of them, of the Corporation executing and
delivering the Merger Agreement deem necessary, advisable and/or desirable, the
execution and delivery of the Merger Agreement on behalf of the Corporation to
be conclusive evidence of the approval thereof; and it is further
RESOLVED,
that at the Effective Time of the Merger, the name of the Surviving Corporation
shall be changed to “SensiVida Medical Technologies, Inc.;” and it is
further
RESOLVED,
that any officer of the Corporation is hereby authorized, empowered and
directed, in the name and on behalf of the Corporation, to execute and file with
the States of Delaware and New Jersey, a Certificate of Ownership, together with
any and all other documents deemed necessary and/or advisable to effect the
Merger; and it is further
RESOLVED, that any officer of the
Corporation is hereby, authorized, empowered and directed, in the name and on
behalf of the Corporation, to take, or cause to be taken, any and all such other
actions (including, without limitation, the execution and delivery of notices,
certificates and other instruments) as in the judgment of such officers, or any
of them, is necessary or appropriate to carry out the foregoing resolutions and
consummate the transactions contemplated thereby; provided, however, that this
resolution shall not be construed to authorize any action which is contrary to
or inconsistent with the foregoing resolutions; and it is further
RESOLVED,
that all acts and deeds heretofore done or actions taken in good faith by any
director or officer of the Corporation in entering into, executing,
acknowledging or attesting any arrangements, agreements, instruments or
documents in carrying out the terms and intentions of the foregoing resolutions
are hereby ratified, confirmed and approved.
9. Approval
of the Merger by the stockholders of the Surviving Corporation is not required
pursuant to Section 10-3(4) of the New Jersey Business Corporation
Act.
10. A
signed copy of the Agreement and Plan of Merger is on file at the office of the
Surviving Corporation at 1235 Folkstone Way, Cherry Hill, New Jersey 08034-3020
and a copy of the Agreement and Plan of Merger will be furnished by the
Surviving Corporation, on request and without cost, to any stockholder of the
constituent corporations of the Merger.
11. The
Surviving Corporation agrees that it may be served with process in the State of
Delaware in any proceeding for enforcement of any obligation of the Subsidiary
Corporation, as well as for enforcement of any obligation of the Surviving
Corporation arising from the Merger, including any suit or other proceeding to
enforce the right of any stockholders as determined in appraisal proceedings
pursuant to Section 262 of the Delaware General Corporation Law, and the
Surviving Corporation hereby irrevocably appoints the Secretary of State of the
State of Delaware as its agent to accept service of process in any such suit or
other proceedings with a copy to the Surviving Corporation at 1235 Folkstone
Way, Cherry Hill, New Jersey 08034-3020.
IN
WITNESS WHEREOF, the Corporation and the Subsidiary Corporation have each caused
this Certificate of Merger to be executed in its name as of ________,
2009.
|
BIOSCOPIX,
INC.
|
|
|
|
|
By:
|
/s/
Peter Katevatis
|
|
Name:
|
Peter
Katevatis
|
|
Title:
|
Chief
Executive Officer and Treasurer
|
|
|
|
|
|
|
|
SENSIVIDA
MEDICAL SYSTEMS, INC.
|
|
|
|
|
|
|
|
By:
|
/s/
Kamal Sarbadhikari
|
|
Name:
|
Kamal
Sarbadhikari
|
|
Title:
|
CEO
|